Beijing Kawin Technology Share-holding Co Ltd - Asset Resilience Ratio
Beijing Kawin Technology Share-holding Co Ltd (688687) has an Asset Resilience Ratio of 9.90% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Beijing Kawin Technology Share-holding C (688687) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2024)
This chart shows how Beijing Kawin Technology Share-holding Co Ltd's Asset Resilience Ratio has changed over time. See Beijing Kawin Technology Share-holding C net assets for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Beijing Kawin Technology Share-holding Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Beijing Kawin Technology Share-holding C worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥284.07 Million | 9.9% |
| Total Liquid Assets | CN¥284.07 Million | 9.90% |
Asset Resilience Insights
- Limited Liquidity: Beijing Kawin Technology Share-holding Co Ltd maintains only 9.90% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Beijing Kawin Technology Share-holding Co Ltd Industry Peers by Asset Resilience Ratio
Compare Beijing Kawin Technology Share-holding Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN |
Biotechnology | 3.28% |
|
Summit Therapeutics PLC
NASDAQ:SMMT |
Biotechnology | 0.00% |
|
Argen-X
F:1AE |
Biotechnology | 25.67% |
|
Zhejiang Ausun Pharmaceutical Co Ltd
SHG:603229 |
Biotechnology | 0.21% |
|
R&G PharmaStudies Co. Ltd. A
SHE:301333 |
Biotechnology | 35.96% |
|
Shouyao Holdings (Beijing) Co. Ltd. A
SHG:688197 |
Biotechnology | 79.48% |
|
Innovita Biological Technology Co. Ltd. A
SHG:688253 |
Biotechnology | 70.49% |
|
Sunmax Biotechnology Co Ltd
TWO:4728 |
Biotechnology | 10.53% |
Annual Asset Resilience Ratio for Beijing Kawin Technology Share-holding Co Ltd (2021–2024)
The table below shows the annual Asset Resilience Ratio data for Beijing Kawin Technology Share-holding Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 13.41% | CN¥350.87 Million ≈ $51.34 Million |
CN¥2.62 Billion ≈ $382.75 Million |
-1.51pp |
| 2023-12-31 | 14.92% | CN¥365.33 Million ≈ $53.46 Million |
CN¥2.45 Billion ≈ $358.25 Million |
-8.21pp |
| 2022-12-31 | 23.13% | CN¥511.12 Million ≈ $74.79 Million |
CN¥2.21 Billion ≈ $323.35 Million |
+19.46pp |
| 2021-12-31 | 3.67% | CN¥80.00 Million ≈ $11.71 Million |
CN¥2.18 Billion ≈ $318.67 Million |
-- |
About Beijing Kawin Technology Share-holding Co Ltd
Beijing Kawin Technology Share-Holding Co., Ltd., a biopharmaceutical company, provides treatment solutions for viral and immune diseases in China and internationally. The company offers recombinant human interferon alfa-2b injection; interferon alfa-2b vaginal effervescent tablets; coblopasvir hydrocholoride capsules; sofosbuvir tablets; peginterferon alfacon-2 injection; and compound glycyrrhiz… Read more